Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/GNT1127825]Researchers: Dr Mark Adams (Principal investigator)
Brief description Lung cancer is the leading cause of cancer-related mortality worldwide. This project will establish the worth of suppressing the molecule ‘cell division cycle associated protein 3’ (CDCA3) in lung cancer. To do so, we will adjust the levels of CDCA3 in animal lung cancer models and treat the tumours with chemotherapy and the novel drug CX-4945. We expect that reduced levels of CDCA3 combined with CX-4945 and/or chemotherapy in NSCLC patients will benefit patient outcome.
Funding Amount $194,446.00
Funding Scheme Project Grants
Notes New Investigator Grant
- nhmrc : GNT1127825
- PURL : https://purl.org/au-research/grants/nhmrc/GNT1127825
